BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32319590)

  • 1. CD38 is involved in cell energy metabolism via activating the PI3K/AKT/mTOR signaling pathway in cervical cancer cells.
    Liao S; Liang L; Yue C; He J; He Z; Jin X; Luo G; Zhou Y
    Int J Oncol; 2020 Jul; 57(1):338-354. PubMed ID: 32319590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway.
    Feng T; Zheng L; Liu F; Xu X; Mao S; Wang X; Liu J; Lu Y; Zhao W; Yu X; Tang W
    Oncotarget; 2016 Sep; 7(36):58381-58395. PubMed ID: 27517315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
    Lu R; Yang Z; Xu G; Yu S
    Biomed Pharmacother; 2018 Sep; 105():633-644. PubMed ID: 29898430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines.
    Dan VM; Muralikrishnan B; Sanawar R; J S V; Burkul BB; Srinivas KP; Lekshmi A; Pradeep NS; Dastager SG; Santhakumari B; Santhoshkumar TR; Kumar RA; Pillai MR
    Sci Rep; 2018 Feb; 8(1):2810. PubMed ID: 29434241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Cyperone inhibits the proliferation of human cervical cancer HeLa cells via ROS-mediated PI3K/Akt/mTOR signaling pathway.
    Pei XD; Yao HL; Shen LQ; Yang Y; Lu L; Xiao JS; Wang XY; He ZL; Jiang LH
    Eur J Pharmacol; 2020 Sep; 883():173355. PubMed ID: 32687921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
    Li X; Zhao J; Yan T; Mu J; Lin Y; Chen J; Deng H; Meng X
    J Food Sci; 2021 Jun; 86(6):2700-2712. PubMed ID: 33908630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.
    Bian P; Hu W; Liu C; Li L
    Arch Biochem Biophys; 2020 Aug; 689():108461. PubMed ID: 32531316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
    Liu Y; Zhao Y; Guo L
    Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway.
    Zhang L; Li J; Zhang L
    Contrast Media Mol Imaging; 2022; 2022():8497078. PubMed ID: 36237584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy.
    Bahrami A; Hasanzadeh M; Hassanian SM; ShahidSales S; Ghayour-Mobarhan M; Ferns GA; Avan A
    J Cell Biochem; 2017 Dec; 118(12):4163-4169. PubMed ID: 28475243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
    Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
    Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
    Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
    Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 enhances the proliferation and inhibits the apoptosis of cervical cancer cells by affecting the mitochondria functions.
    Liao S; Xiao S; Chen H; Zhang M; Chen Z; Long Y; Gao L; Zhu G; He J; Peng S; Xiong W; Zeng Z; Li Z; Zhou M; Li X; Ma J; Wu M; Xiang J; Li G; Zhou Y
    Mol Carcinog; 2017 Oct; 56(10):2245-2257. PubMed ID: 28544069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.
    Rashmi R; DeSelm C; Helms C; Bowcock A; Rogers BE; Rader JL; Rader J; Grigsby PW; Schwarz JK
    PLoS One; 2014; 9(4):e92948. PubMed ID: 24705275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.